Wee Han Ang

25PUBLICATIONS
35CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Biomolecular modelling and designMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Dec 23, 2025
Organoplatinum(II) Type II Immunogenic Cell Death Inducers Target Protein Tyrosine Phosphatase 1B to Drive Immunogenicity.

Jiao Xia Zou, Pavel A Ivanov-Rostovtsev, Jemma Arakelyan

|Mar 31, 2025
Metal-based immunogenic cell death inducers for cancer immunotherapy.

Jiao Xia Zou, Meng Rui Chang, Nikita A Kuznetsov

|Feb 14, 2024
Cisplatin drives mitochondrial dysregulation in sensory hair cells.

David S Lee, Angela Schrader, Jiaoxia Zou

|Dec 13, 2023
Using Machine Learning to Predict the Antibacterial Activity of Ruthenium Complexes.

Markus Orsi, Boon Shing Loh, Cheng Weng

|Aug 25, 2023
Harnessing Transition Metal Scaffolds for Targeted Antibacterial Therapy.

Cheng Weng, Yong Leng Kelvin Tan, Wayne Gareth Koh

|Mar 07, 2023
Targeting Pathogenic Formate-Dependent Bacteria with a Bioinspired Metallo-Nitroreductase Complex.

Cheng Weng, Hui Yang, Boon Shing Loh

Pageof 5